World's Best Scientists 2026 revealed!
Detlef Zillikens

Detlef Zillikens

D-Index & Metrics

Immunology

D-Index
102
Citations
35996
World Ranking
680
National Ranking
40

Medicine

D-Index
102
Citations
36627
World Ranking
7694
National Ranking
437

Detlef Zillikens publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Detlef Zillikens sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 651 publications — 95th percentile

95% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Detlef Zillikens D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Detlef Zillikens sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 102 D-Index — 87th percentile

87% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Detlef Zillikens was affiliated with the University of Lübeck in Germany and contributed extensively to research in the field of medicine, focusing notably on autoimmune bullous skin diseases and related dermatological conditions. Their work spanned over 361 publications in medicine, with notable specialization in pathology and forensic medicine, rheumatology, genetics, dermatology, and epidemiology.

The scientist's research covered significant topics including:

  • Autoimmune Bullous Skin Diseases
  • Urticaria and Related Conditions
  • Coagulation, Bradykinin, Polyphosphates, and Angioedema
  • Dermatology and Skin Diseases
  • Platelet Disorders and Treatments
  • Nail Diseases and Treatments
  • Cancer Immunotherapy and Biomarkers

Zillikens contributed to various high-impact publication venues, often publishing in journals such as:

  • JDDG Journal der Deutschen Dermatologischen Gesellschaft
  • Journal of the European Academy of Dermatology and Venereology
  • Frontiers in Immunology
  • Journal of Investigative Dermatology
  • Frontiers in Medicine

Their collaborative work involved frequent co-authorships with researchers including Enno Schmidt, Ralf J. Ludwig, Christian D. Sadik, Katharina Boch, and Christoph M. Hammers.

Major papers authored or co-authored by Zillikens include:

  • "Updated S2K guidelines on the management of pemphigus vulgaris and foliaceus initiated by the european academy of dermatology and venereology (EADV)", 2020, Journal of the European Academy of Dermatology and Venereology
  • "UpdatedS2K guidelines for the management of bullous pemphigoid initiated by the European Academy of Dermatology and Venereology (EADV)", 2022, Journal of the European Academy of Dermatology and Venereology
  • "European Guidelines (S3) on diagnosis and management of mucous membrane pemphigoid, initiated by the European Academy of Dermatology and Venereology - Part II", 2021, Journal of the European Academy of Dermatology and Venereology
  • "Unmet Medical Needs in Chronic, Non-communicable Inflammatory Skin Diseases", 2022, Frontiers in Medicine
  • "European guidelines (S3) on diagnosis and management of mucous membrane pemphigoid, initiated by the European Academy of Dermatology and Venereology - Part I", 2021, Journal of the European Academy of Dermatology and Venereology

Best Publications

  • The first international consensus on mucous membrane pemphigoid: definition, diagnostic criteria, pathogenic factors, medical treatment, and prognostic indicators.

    Lawrence S. Chan;A. Razzaque Ahmed;Grant J. Anhalt;Wolfgang Bernauer

  • S2k guidelines for the treatment of pemphigus vulgaris/foliaceus and bullous pemphigoid: 2019 update

    Enno Schmidt;Michael Sticherling;Miklós Sárdy;Rüdiger Eming

  • Consensus statement on definitions of disease, end points, and therapeutic response for pemphigus

    Dedee F. Murrell;Sarah Dick;A. R. Ahmed;Masayuki Amagai

  • Anti-inflammatory activity of IgG1 mediated by Fc galactosylation and association of FcγRIIB and dectin-1

    Christian M. Karsten;Manoj K. Pandey;Julia Figge;Regina Kilchenstein

  • The clinical phenotype of pemphigus is defined by the anti-desmoglein autoantibody profile

    Masayuki Amagai;Kazuyuki Tsunoda;Detlef Zillikens;Tetsuo Nagai

  • Serum levels of autoantibodies to BP180 correlate with disease activity in patients with bullous pemphigoid.

    Enno Schmidt;Karin Obe;Eva-Bettina Bröcker;Detlef Zillikens

  • Definitions and outcome measures for bullous pemphigoid: Recommendations by an international panel of experts

    Dedee F. Murrell;Benjamin S. Daniel;Pascal Joly;Luca Borradori

  • Melatonin enhances antioxidative enzyme gene expression (CAT, GPx, SOD), prevents their UVR-induced depletion, and protects against the formation of DNA damage (8-hydroxy-2'-deoxyguanosine) in ex vivo human skin.

    Tobias W. Fischer;Konrad Kleszczyński;Lena H. Hardkop;Nathalie Kruse

  • Diagnosis and management of pemphigus: Recommendations of an international panel of experts

    Dedee F. Murrell;Sandra Peña;Sandra Peña;Pascal Joly;Branka Marinovic

  • Tight Clustering of Extracellular BP180 Epitopes Recognized by Bullous Pemphigoid Autoantibodies

    Detlef Zillikens;Pamela A. Rose;Shawn D. Balding;Zhi Liu

  • Prospective analysis of the incidence of autoimmune bullous disorders in Lower Franconia, Germany

    Franziska Bertram;Eva‐B. Bröcker;Detlef Zillikens;Detlef Zillikens;Enno Schmidt;Enno Schmidt

  • Management of bullous pemphigoid: the European Dermatology Forum consensus in collaboration with the European Academy of Dermatology and Venereology

    Claudio Feliciani;P. Joly;M. F. Jonkman;G. Zambruno

  • Pemphigus. S2 Guideline for diagnosis and treatment – guided by the European Dermatology Forum (EDF) in cooperation with the European Academy of Dermatology and Venereology (EADV)

    M Hertl;H Jedlickova;S Karpati;B Marinovic

  • A Comparison of Oral Methylprednisolone Plus Azathioprine or Mycophenolate Mofetil for the Treatment of Pemphigus

    Stefan Beissert;Thomas Werfel;Uta Frieling;Markus Böhm

  • Updated S2K guidelines on the management of pemphigus vulgaris and foliaceus initiated by the european academy of dermatology and venereology (EADV).

    P. Joly;B. Horvath;Α Patsatsi;S. Uzun

  • Incidence of Autoimmune Subepidermal Blistering Dermatoses in a Region of Central Germany

    Detlef Zillikens;Sabine Wever;Alexa Roth;Beate Weidenthaler-Barth

  • Induction of dermal-epidermal separation in mice by passive transfer of antibodies specific to type VII collagen

    Cassian Sitaru;Sidonia Mihai;Christoph Otto;Mircea T. Chiriac

  • A novel subepidermal blistering disease with autoantibodies to a 200-kDa antigen of the basement membrane zone

    Detlef Zillikens;Detlef Zillikens;Yoshie Kawahara;Akira Ishiko;Hiroshi Shimizu

  • A Highly Sensitive Enzyme-Linked Immunosorbent Assay for the Detection of Circulating Anti-BP180 Autoantibodies in Patients with Bullous Pemphigoid

    Detlef Zillikens;Jose M. Mascaro;Pamela A. Rose;Zhi Liu

  • Risk factors for lethal outcome in patients with bullous pemphigoid: low serum albumin level, high dosage of glucocorticosteroids, and old age.

    Berthold Rzany;Karin Partscht;Martin Jung;Werner Kippes

  • The Shed Ectodomain of Collagen XVII/BP180 Is Targeted by Autoantibodies in Different Blistering Skin Diseases

    Hauke Schumann;Jens Baetge;Kaisa Tasanen;Kaisa Tasanen;Fenella Wojnarowska

  • Anti-laminin gamma-1 pemphigoid

    Teruki Dainichi;Sadamu Kurono;Bungo Ohyama;Norito Ishii

  • Development of ELISA for the specific determination of autoantibodies against envoplakin and periplakin in paraneoplastic pemphigus.

    Christian Probst;Wolfgang Schlumberger;Winfried Stöcker;Andreas Recke

  • Anti‐p200 pemphigoid: A novel autoimmune subepidermal blistering disease

    Amrei Dilling;Christian Rose;Takashi Hashimoto;Detlef Zillikens

  • Serum autoantibodies against the dermal-epidermal junction in patients with chronic pruritic disorders, elderly individuals and blood donors prospectively recruited.

    N. van Beek;A. Dohse;F. Riechert;V. Krull

Frequent Co-Authors

Enno Schmidt
Enno Schmidt University of Lübeck
Ralf Ludwig
Ralf Ludwig University of Rostock
Cassian Sitaru
Cassian Sitaru University of Freiburg
Eva-B. Bröcker
Eva-B. Bröcker University of Würzburg
Takashi Hashimoto
Takashi Hashimoto Osaka Metropolitan University
Marcel F. Jonkman
Marcel F. Jonkman University Medical Center Groningen
Matthias Goebeler
Matthias Goebeler University of Würzburg
Jörg Köhl
Jörg Köhl University of Lübeck
Luis A. Diaz
Luis A. Diaz Memorial Sloan Kettering Cancer Center
Masayuki Amagai
Masayuki Amagai Keio University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in immunology, related healthcare pathways can offer rewarding career opportunities. Many students choose to enhance their understanding by pursuing nursing degrees that complement immunology knowledge, providing hands-on clinical skills in patient care and disease management.

If you’re looking for programs that balance quality with accessibility, exploring the easiest accelerated nursing programs to get into is a great start. These programs allow students to earn a Bachelor of Science in Nursing (BSN) faster and with fewer barriers.

For those aiming to begin their nursing career quickly, accredited LPN programs can be a practical first step. Check out accredited lpn programs easy to get into for options that provide foundational nursing education and credentials.

Advancing beyond initial nursing roles, many consider specialized degrees. The easiest nurse practitioner program options can help students achieve advanced practice status with less demanding admissions criteria, opening doors to higher responsibility and autonomy.

Specializing in mental health nursing is also a strong career path. The top psychiatric mental health nurse practitioner programs online offer convenient, reputable programs with excellent clinical placement opportunities for those focusing on psychiatric care within immunology-related fields.

Best Scientists Citing Detlef Zillikens

Recently Published Articles